Lysoclear
Business Services · Louisiana, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Lafayette, Louisiana, United StatesPhone Number
(518) 420-5004Website
www.lysoclear.comRevenue
<$5 MillionIndustry
About Lysoclear
Is Lysoclear your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Lysoclear recently announced quarterly report
Check if Lysoclear has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Lysoclear launches new products
Lysoclear, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Lysoclear
Check out if Lysoclear is spiking on competitors!
Funding: Get notified immidiatlly once Lysoclear has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Lysoclear had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Lysoclear
Find 3 more new buyers
Compare Similar Companies to Lysoclear
Compare insights from companies similar to Lysoclear, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Lysoclear
Company Profile Activity
Activity Insights
Lysoclear is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Lysoclear is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Lysoclear.
Lysoclear Tech Stack
A closer look at the technologies used by Lysoclear
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Lysoclear
Lysoclear, Inc. is a pre-clinical company under the Ichor Therapeutics portfolio that specializes in developing enzyme therapies for eye diseases, specifically targeting atrophic dry age-related macular degeneration and Stargardt’s macular degeneration. The company focuses on addressing the accumulation of toxic vitamin A aggregates in retinal pigm... Read More